Affiliation: Barrow Neurological Institute
- Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomasMarkus Bredel
Division of Oncology, Center for Clinical Sciences Research, Institute for Computational and Mathematical Engineering, Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305 5151, USA
J Clin Oncol 24:274-87. 2006..Pre-existing and acquired drug resistance are major obstacles to the successful treatment of glioblastomas...
- Emerging evidence of hepatitis C virus neuroinvasionTomasz Laskus
Department of Medicine, Mayo Clinic Scottsdale, Scottsdale, Arizona 85259, USA
AIDS 19:S140-4. 2005..However, despite some similarities there is a fundamental difference between HIV-1 and HCV infection as the latter does not progress into AIDS-type dementia...
- The ketogenic diet for the treatment of glioma: insights from genetic profilingAdrienne C Scheck
Neuro Oncology Research, Barrow Neurological Institute of St Joseph s Hospital and Medical Center, 350W Thomas Rd, Phoenix, AZ 85013, USA
Epilepsy Res 100:327-37. 2012....
- Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosoureaNicole C Hank
Neuro Oncology Research, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, Phoenix, AZ 85013, USA
BMC Cancer 6:2. 2006..While cells from untreated gliomas often have over-representation of chromosome 7, chromosome 22 is typically under-represented...
- The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for gliomaPhillip Stafford
Neuro Oncology Research, Barrow Neurological Institute7 of St, Joseph s Hospital and Medical Center, Phoenix, AZ, 85013, USA
Nutr Metab (Lond) 7:74. 2010....
- Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cellsAdrienne C Scheck
Neuro Oncology Research, Barrow Neurological Institute of St Joseph s Hospital and Medical Center, Phoenix, AZ 85013, USA
BMC Complement Altern Med 6:27. 2006..We assessed the ability of an ethanolic extract of S. baicalensis root to inhibit the proliferation of malignant glioma cells...
- Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblasKris A Smith
Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA
J Neurosurg 109:106-17. 2008....
- Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissueWolfgang K Pfisterer
Neurosurgery Research, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, Phoenix, AZ 85013, USA
J Neurooncol 87:43-50. 2008..001), and with tumor recurrence (p < 0.01). The findings suggest that adding FISH analysis may allow better prediction of possible meningioma recurrence and may be a useful adjunct for therapy decisions...
- Miniaturized handheld confocal microscopy for neurosurgery: results in an experimental glioblastoma modelTejas Sankar
Division of Neurological Surgery, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, Phoenix, Arizona 85013, USA
Neurosurgery 66:410-7; discussion 417-8. 2010..Clinical confocal imaging applications have emerged, including assessment of colonic mucosal dysplasia during colonoscopy. We present our initial experience with handheld, miniaturized confocal imaging in a murine brain tumor model...
- Molecular biological determinants of meningioma progression and aggressive behaviorAdrienne C Scheck
Division of Neuro Oncology and Neurosurgery Research, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, 350 W Thomas Road, Phoenix, Arizona 85013, USA
Front Biosci (Elite Ed) 1:390-414. 2009..The identification of a marker of aggressive behavior would allow the development of improved clinical protocols based on early intervention for those patients likely to experience a recurrence...
- Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: is it possible to identify a clinically-aggressive subset of benign meningiomas?Wolfgang K Pfisterer
Neurosurgery and Neuro Oncology Research, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, Phoenix, Arizona 85013, USA
Neurosurgery 61:1048-59; discussion 1060-1. 2007....
- Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomasWolfgang K Pfisterer
Neuro Oncology Research and Neurosurgery Research Laboratory, Barrow Neurological Institute of St Joseph s Hospital and Medical Center, Phoenix, AZ 85013, USA
Neuro Oncol 6:290-9. 2004..05). We conclude that the appearance of chromosomal aberrations in different areas of the tumor demonstrates the importance of regional heterogeneity in the biological behavior of meningiomas...
- GLIOMA HETEROGENEITY AND CHEMOSENSITIVITYAdrienne Scheck; Fiscal Year: 2002..The clinical significance of these findings will be validated in fresh frozen and paraffin embedded samples by analyzing tissue from their extensive tumor bank (Specific Aim 4). ..